The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
The NHS will provide a life-extending prostate cancer drug to thousands of men in England, expanding access to a treatment clinically proven to improve survival rates.
If technology seeks to transform oncology practice, it must solve three big needs: data, training and trust. Annemiek Snoeckx, Co-Chair of the Digital Health Network at the European Cancer Organisation, explains.
Surabhi Srivastava, Commercial Head UK and EU at Qure.ai, discusses how integrating artificial intelligence can reduce chest X-ray reporting times and accelerate early lung cancer diagnosis.
Researchers at the University of Warwick have created a quantum diamond sensor, a diamond-based magnetometer capable of accurately detecting cancer cells.
Researchers have shown that AI can detect early laryngeal cancer and related lesions from voice recordings, offering a simple, non-invasive screening option.
University Hospital Southampton is implementing Aiforia’s PD-L1 lung cancer AI solution to assess PD-L1 staining in lung cancer specimens. Dr Vipul Foria and Dr Victoria Elliot describe their journey so far.
Researchers have developed a lung cancer treatment that delivers healthy mitochondria to tumours, boosting T cell activity and improving the effectiveness of cisplatin chemotherapy with reduced toxicity.
The Lancet Commission finds that over three in five liver cancer cases are due to modifiable risks like hepatitis, alcohol, and obesity, highlighting urgent prevention needs.
UCL and UCLH launch the Win‑Glio trial led by Dr Paul Mulholland, offering ipilimumab immunotherapy to newly diagnosed glioblastoma patients ahead of standard treatment.
The NHS Cancer Programme has awarded £14.4 million through SBRI Healthcare to support 16 pioneering projects aimed at improving early cancer detection and diagnosis across the UK.
New results from a clinical trial reveal that a single dose of psilocybin can provide sustained reductions in depression and anxiety in individuals with cancer suffering from major depressive disorder.
A groundbreaking study from the Paul Scherrer Institute (PSI) in collaboration with Inselspital–Bern University Hospital has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161.
